Secondly, we employed genetic instruments to proxy trait/drug exposure, which may help reduce confounding bias and prevent reverse causation
Clinical trials show approximately 2040% of total weight lost with GLP-1 medications includes lean mass, comparable to dietary restriction and bariatric surgery
Given that weight control and a low risk of hypoglycaemia are key considerations for this patient, the addition of a GLP-1RA may be the most appropriate choice
GLP-1 Receptor agonists and related mental health issues
Prevents fatigue and sluggishness that can sometimes occur with weight loss
The Rise of Semaglutide The Generic Form of Wegovy, Ozempic, and Rybelsus With the patent on branded Semaglutide expiring, the market is poised to welcome generic versions